Jeffrey Krotosky CTO, Tronics MEMS, TDK Group Company | Topic: Need for bioMEMS devices from a higher level perspective
Chronic diseases such as diabetes and cardiovascular disease generate a significant burden on health care systems across the world. In the United States, for example, one American will be diagnosed with diabetes or suffer a coronary event every 30 seconds. Additionally these chronic diseases disproportionally impact those in underserved and underrepresented communities across the world due to reduced access to health care. New biosensors developed using MEMS technologies present a unique opportunity to begin closing the health outcome gap occurring to those in underserved communities. Biosensors utilizing MEMS technologies can spearhead the medical community’s ability to deploy low cost, high accuracy field deployable point of care devices in these underserved markets ultimately improving access to health care and health care outcomes.